
After Covid-19, Hepatitis A Outbreak in Kerala: What Are The Symptoms And Causes
Kerala is currently witnessing a sharp rise in hepatitis A infections in Avoly and nearby panchayats in Muvattupuzha, around 47 km from the city. The Health authorities have confirmed around 50 cases so far. The first case was reported on May 30. The incubation period for hepatitis A is two to six weeks, therefore, health authorities expect more cases to surface in the coming days.
Most infected individuals attended a wedding at Nadukkara ward in Avoly panchayat on May 3. The authorities suspect that contaminated food and water served at the function may have triggered the outbreak. Around 150 people from Avoly, Manjalloor and Arakuzha panchayats in Muvattupuzha and Idukki and Alappuzha districts attended the event.
Hepatitis A: Causes, symptoms and more
Hepatitis A is a highly contagious liver infection that usually spreads from contaminated food or water or close contact with an infected person or object. Hepatitis viruses cause liver inflammation and affect your liver's ability to function.
What are the symptoms of hepatitis A?
Hepatitis A symptoms can include:
Fever
Loss of appetite
Diarrhea
Tiredness and weakness
Abdominal discomfort
Dark-coloured urine
Jaundice
Joint pain
Itchy skin
Not everyone who is infected will have all the symptoms. Symptoms are typically mild and go away in a few weeks. However, in some cases, symptoms can last for several months and even lead to severe illness.
How to prevent
Vaccination against hepatitis A is one of the most effective ways to prevent it. The vaccine is typically given in two shots. The first shot is followed by a booster shot. Other preventive measures include:
Avoid raw and undercooked meat and fish
Wash fruits and vegetables thoroughly and avoid pre-cut fruits and vegetables.
Practice good hygiene, especially after using the toilet or changing a diaper and before preparing food or eating
Ensure adequate supplies of safe drinking water
Use of safer sex practices
According to the World Health Organisation, most individuals recover fully from hepatitis A with lifelong immunity. However, a very small proportion of people infected with hepatitis A could die from fulminant hepatitis.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


News18
a day ago
- News18
All About The New COVID-19 Variant Causing 'Razor Blade' Sore Throats
Last Updated: The new variant called the NB.1.8.1 has been detected in the US among travellers coming in from Western Pacific nations, with a rising number of patients. The recent spike in coronavirus cases in certain parts of the world has been attributed to a new variant of the virus that caused a global health pandemic, nicknamed the 'razor blade throat" COVID. The variant is called the NB.1.8.1 or 'Nimbus' and causes painful sore throats among those who come into contact. The symptom has been discovered by scientists in India and the United Kingdom, apart from other parts of the world, according to various media outlets. Just when the world was beginning to move on from the horrors of the global health emergency, coronavirus has sprung back into news and discussions with a rising number of affected persons by the new variant. Fever, chills, cough, shortness of breath and loss of taste or smell are proven symptoms of any COVID variant, but Nimbus especially attacks one's throat. While health experts suggest there isn't a cause for major worries about this form of COVID, here is what you need to know about the variant responsible for the sudden spike in global cases. According to a statement dated May 28 by the World Health Organisation, the variant causing the 'razor blade throat' has been spreading primarily in the eastern Mediterranean, Southeast Asia and western Pacific regions. The new variant is responsible for nearly 11% of the global sequenced samples reported since May. In the United States, airport screening held in California, Washington state, Virginia and New York found travellers coming in from those regions affected by the new variant. The new variant is unlikely to cause any worse damage than other variants of the virus that emerged from China in December 2019. Even though Western Pacific countries have reported an increasing number of cases and persons hospitalised, the WHO says there is no proof to suggest the Nimbus variant comes with a disease and symptoms more dangerous than other variants. Likewise, the vaccines proven effective against those variants will help provide relief against NB.1.8.1 as well. The WHO has marked the public health risk from the new variant at a low level, designating it as a 'variant under monitoring" with current vaccinations remaining effective. Last month, Robert F Kennedy Jr announced that COVID-19 injection shots are no longer recommended for healthy children and women undergoing pregnancy. But public health experts raised an immediate question mark on the claim made by the US Health Secretary. First Published: June 22, 2025, 12:37 IST


The Hindu
2 days ago
- The Hindu
Global recognition for Karnataka's Tobacco Control Cell
Karnataka's State Tobacco Control Cell has been honoured by the World Health Organisation (WHO) for excellence in tobacco control in the South-East Asia region. Each year, the WHO recognises and felicitates the best performing States in the South-East Asia region for their exemplary efforts in tobacco control. Health Minister Dinesh Gundu Rao received the award from WHO representatives in Bengaluru on Saturday. COTPA amendment Tightening tobacco control laws, the Karnataka government last month notified major amendments to the Cigarettes and Other Tobacco Products Act (COTPA), 2003, on the occasion of the World No Tobacco Day observed on May 31. The amendments — through which the maximum fine for violations under tobacco control laws has been increased from ₹200 to ₹1,000, and the legal age for purchasing tobacco products been raised from 18 to 20 years — were approved by President Droupadi Murmu on May 23. The amended Act — the Cigarettes and Other Tobacco Products (Prohibition of Advertisement and Regulation of Trade and Commerce, Production, Supply and Distribution) (Karnataka Amendment) Act, 2024 — was published in the Karnataka Gazette on May 30.


Time of India
3 days ago
- Time of India
India can step up as Living Laboratory for the world, says Union Minister Chandra Shekhar
New Delhi: Reflecting over India's large population base and its diversity, Union Minister Dr. Pemmasani Chandra Sekhar, voiced that the country can step up as a"living laboratory" for the world, and offer scalable models for digital transformation of healthcare. Speaking at the inaugural edition of ETHealthworld FutureMed X - The Smart Patient Care Summit, the Minister of State for Communications & Ministry of Rural Development, said the country has the potential to serve as a "living laboratory" for the world. and building on the existing evidence India can develop its own high-quality scalable solutions and drive healthcare digital transformation.' With collaboration between entrepreneurs and the government, we can make this process successful and ensure that our citizens receive healthcare services that meet global quality standards, the minister added. Delivering the Chief Guest address, Dr Chandra Sekhar noted, with record investment in medical education, the country is nearing to achieve the World Health Organisation (WHO) optimal number of doctors and integration of telemedicine has further boosted access to services. Speaking further, the Union Minister stressed that entrepreneurs in the country can explore innovative business models to address healthcare challenges, such as drone-based delivery of essential medicines and mobile vans equipped with trained MBBS doctors and physicians. Advocating for self-reliance, Dr Chandra Sekhar said that India needs to develop its own system and needs to focus on investing in primary and preventive care. By leveraging digital infrastructure and implementing price controls, along with effective workforce planning, the country can overcome existing healthcare challenges, he added. The inaugural edition FutureMed X - The Smart Patient Care Summit designed to discuss and understand the dynamics of AI-driven diagnostics , IoT-enabled healthcare , telemedicine, and data-driven decision-making—paving the way for a more intelligent, connected, and patient-first healthcare ecosystem.